Question 1

Does BNP Paribas Financial Markets own EGRX stock?

Accepted Answer

No. BNP Paribas Financial Markets exited its EGRX (Eagle Pharmaceuticals) position in Q4 2024. Its Q3 2024 13F listed 17,976 shares worth $67,050.

Question 2

How many shares of EGRX does BNP Paribas Financial Markets own?

Accepted Answer

None since Q4 2024, when BNP Paribas Financial Markets exited the position. Its Q3 2024 13F listed 17,976 shares worth $67,050.

Question 3

What is BNP Paribas Financial Markets' EGRX position worth?

Accepted Answer

BNP Paribas Financial Markets' EGRX position was worth $67,050 in its Q3 2024 13F, before the exit in Q4 2024.

Question 4

Is BNP Paribas Financial Markets buying or selling EGRX?

Accepted Answer

In Q4 2024, BNP Paribas Financial Markets exited its entire EGRX position.

Question 5

When did BNP Paribas Financial Markets first buy EGRX?

Accepted Answer

BNP Paribas Financial Markets already held EGRX in its Q4 2018 13F, the earliest on record, and listed it in 24 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2024-Q4 Latest	Exited	0	-100.0%	$0	0.0%	$0.50	0
2024-Q3	Decreased	17,976	-26.3%	$67,050	0.0%	$3.95	0
2024-Q2	Decreased	24,402	-34.7%	$136,651	0.0%	$5.60	0
2024-Q1	Decreased	37,385	-57.9%	$195,897	0.0%	$5.24	0
2023-Q4	Increased	88,685	+378.7%	$463,823	0.0%	$5.23	39
2023-Q3	Decreased	18,527	-56.9%	$292,171	0.0%	$15.77	0
2023-Q2	Increased	43,019	+121.2%	$836,289	0.0%	$19.47	40
2023-Q1	Decreased	19,446	-22.4%	$551,683	0.0%	$27.88	0
2022-Q4	Increased	25,050	+7.5%	$732,212	0.0%	$29.23	27
2022-Q3	Increased	23,296	+637.2%	$615,480	0.0%	$28.60	39
2022-Q2	Decreased	3,160	-14.9%	$140,399	0.0%	$43.12	0
2022-Q1	Decreased	3,712	-42.0%	$183,707	0.0%	$49.50	0
2021-Q4	Decreased	6,397	-45.8%	$325,735	0.0%	—	0
2021-Q3	Increased	11,793	+171.0%	$657,814	0.0%	—	40
2021-Q2	Increased	4,351	+94.2%	$186,223	0.0%	$42.14	36
2021-Q1	Increased	2,240	+20.9%	$93,498	0.0%	$41.06	26
2020-Q4	Decreased	1,852	-38.3%	$86,248	0.0%	$46.50	0
2020-Q3	Increased	3,002	+67.4%	$127,525	0.0%	$41.88	33
2020-Q2	Decreased	1,793	-91.8%	$86,028	0.0%	$48.02	0
2020-Q1	Increased	21,986	+840.8%	$1M	0.0%	$45.31	40
2019-Q4	Decreased	2,337	-88.1%	$140,407	0.0%	$59.89	0
2019-Q3	Increased	19,616	+2.3%	$1.1M	0.0%	$56.43	26
2019-Q2	Increased	19,185	+637.3%	$1.1M	0.0%	$55.68	41
2019-Q1	Increased	2,602	+545.7%	$131,375	0.0%	$50.49	36
2018-Q4	First report	403	-	$16,237	0.0%	$39.23	0

EGRX25 quarters

EGRX
25 quarters